Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.
about
Anthocyanin-rich purple corn extract inhibit diabetes-associated glomerular angiogenesisHypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transitionAlternative Medicine in Diabetes - Role of Angiogenesis, Oxidative Stress, and Chronic InflammationRenal endothelial dysfunction in diabetic nephropathyAntiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetesClinical therapeutic strategies for early stage of diabetic kidney disease.The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.Molecular mechanisms of diabetic vascular complicationsPodocytes, signaling pathways, and vascular factors in diabetic kidney diseaseVEGF regulates TRPC6 channels in podocytes.Getting a notch closer to understanding diabetic kidney disease.Angiogenesis and chronic kidney disease.Exacerbation of diabetic renal alterations in mice lacking vasohibin-1.The Role of SIRT1 in Diabetic Kidney Disease.Renal microvascular disease determines the responses to revascularization in experimental renovascular diseasePromoting effects of the adipokine, apelin, on diabetic nephropathy.Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytesVascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes.Transcriptome analysis of human diabetic kidney diseaseAssociation of 18bp insertion/deletion polymorphism, at -2549 position of VEGF gene, with diabetic nephropathy in type 2 diabetes mellitus patients of North Indian population.Early systemic microvascular damage in pigs with atherogenic diabetes mellitus coincides with renal angiopoietin dysbalance.Hypoxia-inducible factor signaling in the development of kidney fibrosisGlomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.Albuminuria Is Associated with Endothelial Dysfunction and Elevated Plasma Endothelin-1 in Sickle Cell Anemia.Vegfa protects the glomerular microvasculature in diabetes.Effect of simvastatin on the expression of nephrin, podocin, and vascular endothelial growth factor (VEGF) in podocytes of diabetic rat.Imbalance of angiogenesis in diabetic complications: the mechanisms.What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease.Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic miceCurrent concepts in targeted therapies for the pathophysiology of diabetic microvascular complications.Urgent call for reconsideration of chronic kidney disease.Advanced diabetic nephropathy with nephrotic range proteinuria: a pilot study of the long-term efficacy of subcutaneous ACTH gel on proteinuria, progression of CKD, and urinary levels of VEGF and MCP-1.Abnormal angiogenesis in diabetic nephropathy.Endothelial-podocyte crosstalk: the missing link between endothelial dysfunction and albuminuria in diabetes.Vascular response to vasodilator treatment in microalbuminuric diabetic kidney disease.Renal vascular structure and rarefaction.Abnormalities in signaling pathways in diabetic nephropathy.VEGF and podocytes in diabetic nephropathy.
P2860
Q21132429-12A92A5A-3D03-4EED-A2AC-1FB0366C6294Q24301382-194B661D-4F0C-4CFA-9E3B-600FB39B28AFQ26801343-12160663-4C88-4073-85D5-E9AFB2E53F7AQ27021318-83D48933-126F-4E30-B8D6-F122A431B3FAQ28538183-FDD13869-7CF6-490B-A60B-90334DECF148Q30363683-850F33A1-CE20-4213-B40F-5FEF8DC77AE0Q30497355-C068CFC0-69D0-48E0-BBE1-D9542E2F3372Q33558421-EADE0A73-A575-49AB-8EB8-29B23994F4FCQ33821237-C1DD4A48-40C1-4283-8337-B591B77524C5Q34003179-BAE1ACF1-BFF9-4DFD-967E-A2BBDE525A77Q34024295-D4888E42-6DDF-4740-9D89-AF98997A0C5DQ34075013-9DAFF50C-0A22-4472-AA25-52E5986A91FCQ34257934-F9048255-7034-4E76-821C-B31C08B00B9EQ34312543-ECAC4522-9811-4A4A-99E6-C447BC21F2FAQ34548339-57043A74-A4E9-4710-947D-E05FAF427B7DQ34663765-FA2200EE-E7C2-424C-B6A3-DAB89DA978CAQ34801482-B9EB9C8B-4D6C-4D0A-9E61-06498B00F642Q35073189-BAA3AEB7-6006-46D6-AC23-892F0E9C010AQ35180096-936E172B-FCF4-4AC6-8E5E-D02DBBDFBC1EQ35532060-A3198666-030E-44E7-8C0C-DFD4AC46DE3BQ35536459-57282EE5-1F85-4A53-B47F-E4CF48A4DB6DQ36012603-F4697D61-E45D-46BE-B017-9DC4CB70883AQ36055520-EA8AF05B-9B6C-4167-82A7-32CF57CFB151Q36111664-C83AE4E8-DC5C-4B59-ADFF-5982DC43F97BQ36144830-2DECFE02-E597-49D7-9F0E-E6C8FCFA6278Q36339615-B4290AFF-6D42-40FC-9171-13FB876451C2Q36411779-5F03FB46-053C-4E32-B464-93EFA32DACAAQ36489031-3FB35C67-F63B-4D74-8ADB-350BB332D5E5Q36538396-9414C1A4-291E-4782-8337-D2998EE9299FQ36838665-D8C6F067-7158-4978-9F7C-A4ADD133385CQ36906413-5AACE018-5956-4088-B9DA-E3E5496D8E26Q37058905-1BD6A7E9-FC56-4B51-B1CD-2CE7D7540261Q37195423-3E6412E0-A44F-4C75-B45E-BE2C85CE0775Q37212747-41652BC8-C23E-4DE9-BFFB-8A1D3532D3A9Q37236268-F0C13014-0368-4754-B6D1-9B070AA59A00Q37251105-5E1ED692-B9FF-4AFB-96DB-238B8C357EB5Q37322012-F86F0204-6619-460B-8FF9-1A62877C6F4EQ37605855-315D8556-9323-42B0-A8E6-65489F1FC5D1Q37708046-57D37028-E20A-4316-A420-296A26D36749Q38041671-9609940E-2F57-45E8-BD3A-CE750E33B3D9
P2860
Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Local VEGF activity but not VE ...... g diabetic nephropathy in man.
@en
type
label
Local VEGF activity but not VE ...... g diabetic nephropathy in man.
@en
prefLabel
Local VEGF activity but not VE ...... g diabetic nephropathy in man.
@en
P2093
P356
P1433
P1476
Local VEGF activity but not VE ...... g diabetic nephropathy in man.
@en
P2093
P2888
P304
P356
10.1038/SJ.KI.5000294
P407
P577
2006-05-01T00:00:00Z
P5875
P6179
1034766881